Humira®
Immunosuppressants
Adalimumab / Humira®Avastin®
Antineoplastic agents
Bevacizumab / Avastin®Erbitux®
Antineoplastic agents
Cetuximab / Erbitux®Darzalex®
Antineoplastic agents
Daratumumab / Darzalex®Prolia®
Drugs for treatment of bone diseases
Denosumab / Prolia®Enbrel®
Immunosuppressants
Etanercept / Enbrel®Simponi®
Immunosuppressants
Golimumab / Simponi®Remicade®
Immunosuppressants
Infliximab / Remicade®Opdivo®
Antineoplastic agents
Nivolumab / Opdivo®Gazyvaro®
Antineoplastic agents
Obinutuzumab / Gazyvaro®Xolair®
Drugs for obstructive airway diseases
Omalizumab / Xolair®Synagis®
Immune sera and immunoglobulins
Palivizumab / Synagis®Keytruda®
Antineoplastic agents
Pembrolizumab / Keytruda®Cyramza®
Antineoplastic agents
Ramucirumab / Cyramza®Mabthera®
Antineoplastic agents
Rituximab / Mabthera®Cosentyx®
Immunosuppressant
Secukinumab / Cosentyx®RoActemra®
Immunosuppressants
Tocilizumab / RoActemra®Herceptin®
Antineoplastic agents
Trastuzumab / Herceptin®Stelara®
Immunosuppressants
Ustekinumab / Stelara®Evidence for Analytics
